SCHEMBL828613

SCHEMBL828613

C1=C2CNCCC2CCC1

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.34
HTR3A P46098 1/20 0.33
SLC18A3 Q16572 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
KDM1A O60341 1/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL3899156 0.93 HTR2C (0.34) HRH4HTR3A
SCHEMBL1586586 0.92 KDM1A (0.31) KDM1AMAPT
SCHEMBL6788944 0.87
Quinoxaline SCHEMBL7485007 0.83 MEN1 (0.35) SLC18A3SIGMAR1
SCHEMBL1650443 0.82 HRH4 (0.37) HRH4HTR3ASLC18A3SIGMAR1MAPT
SCHEMBL571897 0.81
SCHEMBL14741159 0.81
SCHEMBL32689488 0.81
Hydrochloric Acid SCHEMBL9391692 0.79 KDM1A (0.31) KDM1A
SCHEMBL27752202 0.79 KDM1A (0.44) HRH4HTR3ASLC18A3SIGMAR1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 853 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227270-B1 HETEROCYCLIC DERIVATIVES AND USE THEREOF C&C RES LAB (KR) 2024-11-13 EP claimed
CN-112457247-A Synthesis method of dextromethorphan chiral intermediate 江苏宝众宝达药业有限公司 2021-03-09 CN claimed
CN-104761496-B Synthesis method of dextromethorphan intermediate 华东理工大学 2017-05-24 CN claimed
CN-105524971-A Novel method for resolving 1-(4-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline through enzyme catalysis TIANJIN INST IND BIOTECHNOLOGY 2016-04-27 CN claimed
US-9139552-B2 Indeno-fused naphthopyrans having ethylenically unsaturated groups TRANSITIONS OPTICAL, INC. (US) 2015-09-22 US claimed
CN-104761494-A Preparation method of (S) or (R)-1-(4-methoxy benzyl)-1,2,3,4,5,6,7,8-octahydro isoquinoline SHANGHAI INST PHARM INDUSTRY 2015-07-08 CN claimed
CN-104761496-A Synthesis method of dextromethorphan intermediate UNIV EAST CHINA SCIENCE & TECH 2015-07-08 CN claimed
CN-103319406-A Resolution of 1-(4-methoxybenzyl)-octahydro-isoquinoline DIVIS LAB LTD 2013-09-25 CN claimed
CN-103288731-A Preparation method of dimemorfan phosphate intermediate SICHUAN BIOKIN PHARMACEUTICAL CO LTD 2013-09-11 CN claimed
CN-103265489-A Preparation method of ent-(14S)-3-methoxyl-17-morphinan Suzhou lixin pharmaceutical co ltd 2013-08-28 CN claimed
US-7229986-B2 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2007-06-12 US claimed
CN-1639127-A Process for asymmetric hydrogenation of hexahydroquinoline salts DSM IP ASSETS BV (NL) 2005-07-13 CN claimed
CN-1139576-C Process for manufacture of optically active (R)-or (S)-1-(4-methoxy-benzyl)-8-octahydro-isoquinoline adducts of the general formula - 2004-02-25 CN claimed
US-6337330-B1 Antitussives TORAY INDUSTRIES, INC. (JP) 2002-01-08 US claimed
EP-1150565-A1 THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION bioscience AG (DE) 2001-11-07 EP claimed
WO-2000045635-A1 THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2000-08-10 WO claimed
EP-0998928-A1 ANTITUSSIVES TORAY INDUSTRIES, INC. (JP) 2000-05-10 EP claimed
CN-1186073-A Process for manufacture of optically active (R)-or (S)-1-(4-methoxy-benzyl)-8-octahydro-isoquinoline adducts of the general formula HOFFMANN LA ROCHE (CH) 1998-07-01 CN claimed
EP-0023569-B1 DERIVATIVES OF CARBOXYLIC ACIDS, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1983-06-22 EP claimed
EP-0023569-A1 Derivatives of carboxylic acids, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1981-02-11 EP claimed